Alto Neuroscience Promotes CFO to President; $6M Retention

What Happened

• Alto Neuroscience, Inc. filed an 8-K reporting that on August 26, 2026 it promoted Nicholas C. Smith (previously CFO and Chief Business Officer) to President and Chief Financial Officer, effective immediately. Amit Etkin, M.D., Ph.D., remains Chief Executive Officer but no longer holds the title of President. The company executed a Promotion and Retention Agreement with Mr. Smith governing a $6,000,000 retention payment.

Key Details

• Effective date: August 26, 2026; 8‑K filed August 27, 2026.
• Retention payment: $6,000,000 total — $3,000,000 payable within 10 days of the Effective Date and $3,000,000 payable on the 12‑month anniversary.
• Forfeiture/recoupment: If Smith resigns or is terminated for Cause before the two‑year anniversary, he forfeits unpaid amounts and must repay previously paid amounts within 30 days of termination. If the company terminates without Cause, or employment ends due to death or Disability before the two‑year mark, unpaid amounts become payable.
• Dr. Etkin is the company’s principal executive officer; Mr. Smith is the principal financial officer. The Promotion and Retention Agreement is attached as Exhibit 10.1 to the filing.

Why It Matters

• This is a material executive change: the company created/filled the President role with its CFO, shifting senior management responsibilities while keeping Dr. Etkin as CEO.
• The $6M retention payment is a near‑term cash obligation (half payable within 10 days) and a notable compensation expense that investors should consider when evaluating corporate governance, cash flow, and executive incentives.
• The recoupment and payment triggers align incentives and protect the company if Smith leaves early or is terminated for Cause; conversely, the agreement guarantees payment if the company terminates him without Cause.